Imexpharm (STC:IMP) FFO


STC:IMP Imexpharm Corp STC:IMP
98 GF Score
Price ₫42,900.00
GF Value ₫51,651.19
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Imexpharm FFO?

FFO (Funds from operations) only applies to REITs.

STC:IMP
98GF Score
Imexpharm Corp STC:IMP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Imexpharm (STC:IMP) Overvalued in 2026?

Based on GuruFocus' analysis, Imexpharm stock appears to be undervalued. The current stock price of ₫42,900.00 is trading 16.9% below its estimated GF Value™ of ₫51,651.19. GuruFocus considers Imexpharm to be Modestly Undervalued.

Key valuation signals for STC:IMP:

  • FFO:
  • GF Value™: ₫51,651.19 vs. price of ₫42,900.00 (16.9% below fair value)
  • GF Score™: 98/100 with 2 warning signs

No single metric tells the full story. See the STC:IMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Imexpharm Business Description

Address 4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. The company's products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.
98GF Score

Get the complete analysis for STC:IMP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫42,900.00
Price
₫51,651.19
GF Value